New era of health science for Africa
President Cyril Ramaphosa hailed the opening of a new vaccine plant in Cape Town as Africa’s ticket into a new era of health science during its launch earlier today.
South African-born health technologies billionaire, Dr Patrick Soon-Shiong, joined Ramaphosa as they proudly cut the ribbon. The NantSA vaccine plant is expected to produce a billion COVID-19 vaccine doses by 2025.
“We want to manufacture this in Africa for Africa and export it to the world. President Ramaphosa said ‘come home, we will make this happen,’” said Soon-Shiong.
The NantSA vaccine production hub is situated in Brackenfell’s Brackengate Business Park. It will also produce cancer vaccines and next-generation cell-based immunotherapies which would make it the biggest such factory in Africa. Most importantly, it could speed up the continent’s COVID-19 vaccination rollout.
‘New era of health science for Africa’
Ramaphosa said that this facility would help boost South Africa’s pharmaceutical manufacturing capabilities.
“This state-of-the-art vaccine manufacturing campus is part of a far broader initiative to propel Africa into a new era of health science,” said Ramaphosa.
The South African unit of Soon-Shiong’s NantWorks LLC, was established last year. Soon-Shiong said an estimated R3 billion is needed for plants to be located in several countries.
A chance for the continent to catch up
Africa has struggled to secure vaccines while wealthy countries were administrating shots to their citizens. Statistics show that only 10.1% of the African population (1.2 billion) have been fully vaccinated compared with 62% of Americans and 72% of people in the United Kingdom (UK).
Soon-Shiong’s ImmunityBio Inc. is developing a messenger ribonucleic acid (mRNA) COVID-19 vaccine which they hope can be used as a universal booster. This could help end the pandemic by targeting the nucleocapsid protein at the core of the coronavirus which is less prone to mutation than the spike proteins targeted by other shots.
The vaccine plant which could employ between 400 to 600 people, is dependent on the vaccine which companies are developing and getting approval for. Several countries including South Africa, Botswana and Australia are currently conducting trials.
A step in the right direction
Ramaphosa said that this coalition would help Africa address its health challenges.
We welcome partnerships with entities like the Access to Advanced Health Institute, the Chan Soon-Shiong Family Foundation and NantWorks to mobilise investment, transfer technology and know-how, and develop skills. We are already seeing the benefits of this partnership. pic.twitter.com/VLKFlNLi1V
— Cyril Ramaphosa 🇿🇦 (@CyrilRamaphosa) January 19, 2022
“This NantSA facility will complement the work already done by companies like Aspen, Biovac and Afrigen here in SA. Our goal is to cover the entire vaccine production value chain by upgrading existing capacity and bringing new capacity on board,” said Ramaphosa. – Health-e News
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
New era of health science for Africa
by Nompilo Gwala, Health-e News
January 19, 2022